vs
Healthpeak Properties（DOC）与Dorman Products, Inc.（DORM）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是Dorman Products, Inc.的1.3倍（$719.4M vs $537.9M），Healthpeak Properties净利率更高（73.2% vs 2.1%，领先71.0%），Healthpeak Properties同比增速更快（3.1% vs 0.8%），Healthpeak Properties自由现金流更多（$357.0M vs $33.5M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 7.1%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
多尔曼产品公司是美国知名的汽车售后配件制造商，成立于1918年，总部位于宾夕法尼亚州科尔马，在纳斯达克上市，股票代码为DORM，深耕汽车售后市场多年，为市场提供丰富的替换零部件产品。
DOC vs DORM — 直观对比
营收规模更大
DOC
是对方的1.3倍
$537.9M
营收增速更快
DOC
高出2.3%
0.8%
净利率更高
DOC
高出71.0%
2.1%
自由现金流更多
DOC
多$323.5M
$33.5M
两年增速更快
DOC
近两年复合增速
7.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $537.9M |
| 净利润 | $114.0M | $11.6M |
| 毛利率 | — | 42.6% |
| 营业利润率 | 17.4% | 5.8% |
| 净利率 | 73.2% | 2.1% |
| 营收同比 | 3.1% | 0.8% |
| 净利润同比 | 2406.4% | -78.8% |
| 每股收益（稀释后） | $0.16 | $0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCDORM
| Q4 25 | $719.4M | $537.9M | ||
| Q3 25 | $705.9M | $543.7M | ||
| Q2 25 | $694.3M | $541.0M | ||
| Q1 25 | $702.9M | $507.7M | ||
| Q4 24 | $698.0M | $533.8M | ||
| Q3 24 | $700.4M | $503.8M | ||
| Q2 24 | $695.5M | $503.0M | ||
| Q1 24 | $606.6M | $468.7M |
净利润DOCDORM
| Q4 25 | $114.0M | $11.6M | ||
| Q3 25 | $-117.1M | $76.4M | ||
| Q2 25 | $31.7M | $58.7M | ||
| Q1 25 | $42.8M | $57.5M | ||
| Q4 24 | $4.5M | $54.5M | ||
| Q3 24 | $85.9M | $55.3M | ||
| Q2 24 | $146.0M | $47.4M | ||
| Q1 24 | $6.7M | $32.8M |
毛利率DOCDORM
| Q4 25 | — | 42.6% | ||
| Q3 25 | 58.6% | 44.4% | ||
| Q2 25 | 60.2% | 40.6% | ||
| Q1 25 | 61.1% | 40.9% | ||
| Q4 24 | 60.3% | 41.5% | ||
| Q3 24 | 60.0% | 40.5% | ||
| Q2 24 | 60.6% | 39.6% | ||
| Q1 24 | 59.8% | 38.7% |
营业利润率DOCDORM
| Q4 25 | 17.4% | 5.8% | ||
| Q3 25 | 9.2% | 19.4% | ||
| Q2 25 | 5.7% | 15.2% | ||
| Q1 25 | 7.7% | 15.8% | ||
| Q4 24 | -2.2% | 16.3% | ||
| Q3 24 | 14.1% | 15.7% | ||
| Q2 24 | 22.3% | 14.4% | ||
| Q1 24 | 3.7% | 11.6% |
净利率DOCDORM
| Q4 25 | 73.2% | 2.1% | ||
| Q3 25 | -16.6% | 14.1% | ||
| Q2 25 | 4.6% | 10.9% | ||
| Q1 25 | 6.1% | 11.3% | ||
| Q4 24 | 0.7% | 10.2% | ||
| Q3 24 | 12.3% | 11.0% | ||
| Q2 24 | 21.0% | 9.4% | ||
| Q1 24 | 1.1% | 7.0% |
每股收益（稀释后）DOCDORM
| Q4 25 | $0.16 | $0.38 | ||
| Q3 25 | $-0.17 | $2.48 | ||
| Q2 25 | $0.05 | $1.91 | ||
| Q1 25 | $0.06 | $1.87 | ||
| Q4 24 | $0.02 | $1.76 | ||
| Q3 24 | $0.12 | $1.80 | ||
| Q2 24 | $0.21 | $1.53 | ||
| Q1 24 | $0.01 | $1.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $49.4M |
| 总债务越低越好 | $9.8B | $440.6M |
| 股东权益账面价值 | $7.5B | $1.5B |
| 总资产 | $20.3B | $2.5B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资DOCDORM
| Q4 25 | $467.5M | $49.4M | ||
| Q3 25 | $91.0M | $55.5M | ||
| Q2 25 | $89.4M | $56.8M | ||
| Q1 25 | $70.6M | $60.6M | ||
| Q4 24 | $119.8M | $57.1M | ||
| Q3 24 | $180.4M | $45.1M | ||
| Q2 24 | $106.9M | $47.5M | ||
| Q1 24 | $101.8M | $34.4M |
总债务DOCDORM
| Q4 25 | $9.8B | $440.6M | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | $468.8M | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCDORM
| Q4 25 | $7.5B | $1.5B | ||
| Q3 25 | $7.6B | $1.5B | ||
| Q2 25 | $7.9B | $1.4B | ||
| Q1 25 | $8.2B | $1.3B | ||
| Q4 24 | $8.4B | $1.3B | ||
| Q3 24 | $8.6B | $1.2B | ||
| Q2 24 | $8.8B | $1.2B | ||
| Q1 24 | $8.9B | $1.2B |
总资产DOCDORM
| Q4 25 | $20.3B | $2.5B | ||
| Q3 25 | $19.6B | $2.6B | ||
| Q2 25 | $19.8B | $2.5B | ||
| Q1 25 | $19.8B | $2.4B | ||
| Q4 24 | $19.9B | $2.4B | ||
| Q3 24 | $20.0B | $2.4B | ||
| Q2 24 | $20.2B | $2.3B | ||
| Q1 24 | $20.5B | $2.2B |
负债/权益比DOCDORM
| Q4 25 | 1.31× | 0.30× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | 0.36× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $41.6M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $33.5M |
| 自由现金流率自由现金流/营收 | 49.6% | 6.2% |
| 资本支出强度资本支出/营收 | 124.4% | 1.5% |
| 现金转化率经营现金流/净利润 | 10.99× | 3.60× |
| 过去12个月自由现金流最近4个季度 | — | $75.7M |
8季度趋势，按日历期对齐
经营现金流DOCDORM
| Q4 25 | $1.3B | $41.6M | ||
| Q3 25 | $315.0M | $12.2M | ||
| Q2 25 | $363.5M | $8.5M | ||
| Q1 25 | $279.4M | $51.2M | ||
| Q4 24 | $1.1B | $71.4M | ||
| Q3 24 | $318.2M | $44.3M | ||
| Q2 24 | $316.2M | $63.3M | ||
| Q1 24 | $152.6M | $52.0M |
自由现金流DOCDORM
| Q4 25 | $357.0M | $33.5M | ||
| Q3 25 | — | $1.8M | ||
| Q2 25 | — | $98.0K | ||
| Q1 25 | — | $40.3M | ||
| Q4 24 | $333.7M | $63.2M | ||
| Q3 24 | — | $35.7M | ||
| Q2 24 | — | $51.4M | ||
| Q1 24 | — | $41.2M |
自由现金流率DOCDORM
| Q4 25 | 49.6% | 6.2% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | 47.8% | 11.8% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 10.2% | ||
| Q1 24 | — | 8.8% |
资本支出强度DOCDORM
| Q4 25 | 124.4% | 1.5% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | 105.6% | 1.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 2.4% | ||
| Q1 24 | — | 2.3% |
现金转化率DOCDORM
| Q4 25 | 10.99× | 3.60× | ||
| Q3 25 | — | 0.16× | ||
| Q2 25 | 11.48× | 0.15× | ||
| Q1 25 | 6.52× | 0.89× | ||
| Q4 24 | 235.43× | 1.31× | ||
| Q3 24 | 3.71× | 0.80× | ||
| Q2 24 | 2.17× | 1.34× | ||
| Q1 24 | 22.85× | 1.58× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
DORM
| Light Duty | $428.6M | 80% |
| Heavy Duty | $55.8M | 10% |
| Specialty Vehicle | $53.5M | 10% |
